Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longlong Xie

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Clinical Immunology|August 31, 2023
Proteomic Analysis of Pediatric Hemophagocytic Lymphohistiocytosis: a Comparative Study with Healthy Controls, Sepsis, Critical Ill, and Active Epstein-Barr virus Infection to Identify Altered Pathways and Candidate BiomarkersXun Li, Ting Luo, Haipeng Yan, et al.
Scientific Reports|March 20, 2025
Peptidomics characteristics of pediatric sepsisHaipeng Yan, Xun Li, Ting Luo, et al.
Nature Communications|March 18, 2025
Thermomagnetic liquid metal switches with fast bidirectional responseHaodong Chen, Yuyu Xie, Kaiming Qiao, et al.
Theranostics|May 28, 2019
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the <i>RIP3</i> promoterFeng Shi, Min Zhou, Li Shang, et al.
Theranostics|November 18, 2020
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapyJianmin Hu, Yueshuo Li, Hongde Li, et al.
Theranostics|June 6, 2022
Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: ErratumJianmin Hu, Yueshuo Li, Hongde Li, et al.
Signal Transduction and Targeted Therapy|May 21, 2020
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistanceLonglong Xie, Feng Shi, Yueshuo Li, et al.
Molecular Metabolism|April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesisFeng Shi, Ya He, Jiangjiang Li, et al.
NPJ Precision Oncology|March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replicationYueshuo Li, Feng Shi, Jianmin Hu, et al.
Theranostics|August 22, 2018
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerJiangjiang Li, Ya He, Zheqiong Tan, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Clinical Immunology|August 31, 2023
Proteomic Analysis of Pediatric Hemophagocytic Lymphohistiocytosis: a Comparative Study with Healthy Controls, Sepsis, Critical Ill, and Active Epstein-Barr virus Infection to Identify Altered Pathways and Candidate BiomarkersXun Li, Ting Luo, Haipeng Yan, et al.
Scientific Reports|March 20, 2025
Peptidomics characteristics of pediatric sepsisHaipeng Yan, Xun Li, Ting Luo, et al.
Nature Communications|March 18, 2025
Thermomagnetic liquid metal switches with fast bidirectional responseHaodong Chen, Yuyu Xie, Kaiming Qiao, et al.
Theranostics|May 28, 2019
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the <i>RIP3</i> promoterFeng Shi, Min Zhou, Li Shang, et al.
Theranostics|November 18, 2020
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapyJianmin Hu, Yueshuo Li, Hongde Li, et al.
Theranostics|June 6, 2022
Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: ErratumJianmin Hu, Yueshuo Li, Hongde Li, et al.
Signal Transduction and Targeted Therapy|May 21, 2020
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistanceLonglong Xie, Feng Shi, Yueshuo Li, et al.
Molecular Metabolism|April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesisFeng Shi, Ya He, Jiangjiang Li, et al.
NPJ Precision Oncology|March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replicationYueshuo Li, Feng Shi, Jianmin Hu, et al.
Theranostics|August 22, 2018
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerJiangjiang Li, Ya He, Zheqiong Tan, et al.
Pageof 5